Abbonarsi

Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension - 14/03/12

Doi : 10.1016/j.jaad.2011.08.031 
Jae Yoon Jung, MD a, b, Jong Soo Hong, MD a, b, Chang Ho Ahn, MD a, Ji Young Yoon, MSc b, Hyuck Hoon Kwon, MD a, b, Dae Hun Suh, MD, PhD a, b,
a Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea 
b Acne Research Laboratory, Seoul National University Hospital, Seoul, Korea 

Reprint requests: Dae Hun Suh, Department of Dermatology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.

Abstract

Background

Acne treatments using laser and light devices have been reported to have varying degrees of efficacy. However, there has been no study of treatment of acne using a dual mode (quasi-long pulse and Q-switched mode) 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension.

Objective

To evaluate the clinical efficacy, safety, and histological changes of new laser treatment method for acne vulgaris.

Methods

Twenty-two patients received 3 sessions of quasi-long pulse and Q-switched Nd:YAG laser treatment assisted with a topically applied carbon suspension at 2-week intervals in a randomized split face manner.

Results

At the final visit, the inflammatory acne lesions were reduced on the laser-treated side by 58.6% (P < .001), but increased on the untreated side by 5%. The noninflammatory acne lesions were reduced on the laser-treated side by 52.4% (P < .001). Sebum output reduction, inflammatory cell and cytokine reductions, a decrease of the thickness of a perifollicular stratum corneum and a full epithelium, and skin rejuvenation effect were found. The histopathologic examination of the acne lesions showed decreased inflammation and immunostaining intensity for interleukin 8, matrix metalloproteinase-9, toll-like receptor-2, and nuclear factor kappa B, and tumor necrosis factor alpha was reduced significantly. No severe adverse reactions were reported. All patients reported mild transient erythema that disappeared in a few hours.

Limitations

The number of subjects studied was small.

Conclusions

This laser treatment was rapid and effective for treating not only the inflammatory but also the noninflammatory acne lesions when compared with the control side. The histopathologic findings correlated well with the clinical acne grade and treatment response. This novel laser treatment appears to be safe and effective for acne treatment.

Il testo completo di questo articolo è disponibile in PDF.

Key words : acne, histopathologic examination, Nd:YAG laser, sebum output

Abbreviations used : H&E, HSP, IL, MMP, Nd:YAG, NF-κB, PDL, TGF-β, TLR, TNF-⍺, VAS


Mappa


 Funding sources: None.
 Conflicts of interest: None declared.


© 2012  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 66 - N° 4

P. 626-633 - aprile 2012 Ritorno al numero
Articolo precedente Articolo precedente
  • Current leadership training in dermatology residency programs: A survey
  • David S. Baird, Magdalena Soldanska, Bryan Anderson, Jeffrey J. Miller
| Articolo seguente Articolo seguente
  • Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod
  • Anne Marie Tremaine, Jennifer Armstrong, Yu-Chih Huang, Leila Elkeeb, Arisa Ortiz, Ronald Harris, Bernard Choi, Kristen M. Kelly

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.